Search for: "Armand Co. v. Federal Trade Commission" Results 1 - 2 of 2
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Aug 2009, 8:01 am
Given the compression of competition due to the agreement, the FTC caught wind of the Shire-Barr-Impax agreement and opened an investigation in October 2006: “The US Federal Trade Commission (‘FTC’) informed Shire on October 3, 2006 that it was reviewing the ADDERALL XR patent litigation settlement agreement between Shire and Barr Laboratories, Inc. [read post]